Breakingviews - Viewsroom: Credit Suisse chair, Unilever’s GSK bid
Breakingviews
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Unilever will not raise rejected 50 bln pound bid for GSK consumer armUnilever PLC on Wednesday effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it would not raise its 50 billion pound ($68 billion) offer that GSK previously rejected.
Read more »
Glen Powell, Chris Morgan Team for Sci-Fi Action Thriller ‘Deputy X’ at Universal (Exclusive)Jack Paglen, whose previous credits include 'Transcendence' and 'Alien: Covenant,' will write the script.
Read more »
Unilever Walks Away From Glaxo Consumer-Healthcare DealUnilever, maker of Dove soap and Ben & Jerry’s ice cream, said it won’t boost its $68 billion offer for GlaxoSmithKline’s consumer healthcare business, effectively ending its effort to buy the maker of Aquafresh toothpaste and Advil pain relievers.
Read more »
Financial Market Committee Chair Aksakov Joins Calls for Identification of Russian Crypto Owners – Regulation Bitcoin NewsAnatoly Aksakov, head of Russia's Financial Market Committee, has insisted that Russians owning coins should declare their digital assets.
Read more »
ESMA vice chair calls for proof of work mining banThe vice chair of an influential markets watchdog in Europe has called for a ban on proof of work mining.
Read more »